Compounded Trilostane
65 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
65
Total Reports
5
Deaths Reported
770.0%
Death Rate
Active Ingredients
Compounded Trilostane
Administration Routes
OralUnknown
Species Affected
Dog 65
Most Affected Breeds
Chihuahua 8
Terrier - Boston 4
Dog (unknown) 4
Maltese 4
Terrier - Yorkshire 4
Spaniel (unspecified) 3
Dachshund - Miniature 3
Beagle 3
Retriever - Labrador 3
Dachshund - Standard Long-haired 3
Most Reported Reactions
Underdose 14
INEFFECTIVE, CUSHINGS 9
Lethargy (see also Central nervous system depression in 'Neurological') 9
Elevated serum alkaline phosphatase (SAP) 9
Anorexia 8
Lack of efficacy - NOS 7
Hypoadrenocorticism 7
Diarrhoea 7
Elevated alanine aminotransferase (ALT) 7
Proteinuria 7
Polyuria 6
Abnormal adrenocorticotropic hormone (ACTH) stimulation test 6
Outcome Breakdown
Outcome Unknown
48 (73.8%)
Recovered/Normal
7 (10.8%)
Euthanized
4 (6.2%)
Ongoing
4 (6.2%)
Died
1 (1.5%)
Recovered with Sequela
1 (1.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.